Clinical Trials – Leads and Recommendations

As we come across any information on Clinical Trials, we will post them here. We also encourage you to share any information with us by posting on our Forum by clicking here or sending us a message via our Contact Us page. Please Share!

 

6-25-2018

Below is a list of Clinical Trials found on clinicaltrials.gov that accept patients with carcinosarcoma and are currently recruiting.  

Please visit a study’s website for more information about inclusion and exclusion criteria.

To find detailed information on a study, please go to web address for each trial. If the link does not work, go to https://www.clinicaltrials.gov/ and enter the NCT number (study number).

 

 

  1. A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Relapsed/ Refractory Endometrioid Endometrial or Endometrioid Ovarian Cancer (P204) (P204)

 

2. A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies. 

 

3. A Phase 1/2, Open-Label, Dose-Escalation, Safety Study of INCAGN01949in Subjects With Advanced or Metastatic Solid Tumors

 

  1. Trial On Trabectedin In The Treatment Of Advanced Uterine And Ovarian Carcinosarcoma (CS)_MITO 26 (MITO 26)

 

  1. Paclitaxel/Carboplatin + Galunisertib for Patients With Carcinosarcoma of the Uterus or Ovary

 

  1. A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer

 

  1. Vorinostat (SAHA) in Uterine Sarcoma

 

  1. A study of Nivolumab in Selected Uterine Cancer Patients

 

  1. Mirvetuximab Soravtansine and Rucaparib Camsylate in Treating Participants With Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal Cancer

 

  1. Short Course Vaginal Cuff Brachytherapy in Treating Patients With Stage I-II Endomentrial Cancer (SAVE)

 

  1. Nivolumab and Ipilimumab in Treating Patients with Rare Tumors